Inogen, Inc.

NASDAQ:INGN

Medical - Devices

Healthcare
$5.57 +0.71%

+$0.05 today

Market cap
$144.83M
Beta
1.59
P/E (TTM)
-7.0
EPS (TTM)
-$0.91
52W Low $5.34High $9.13

Volume 0.19M

Average 0.33M

INGN Total Current Liabilities

All obligations due within one year.

Inogen, Inc.NASDAQ: INGN

Total Current Liabilities · Q1 FY2026 · quarter ended Mar 2026

Total current liabilities falls 6.1% from a year ago

Total current liabilities stood at $61.45M at the end of Q1 FY2026, down 6.1% from a year earlier and down 3.3% from the prior quarter. Over 3 fiscal years it compounded at -0.9% a year.

Context

  • Total current liabilities amounted to 21.5% of total assets at the end of Q1 FY2026, up 0.3 pp from a year earlier.
  • Total current liabilities increased in 2 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether total current liabilities keeps falling in the next quarterly balance sheet after a -6.1% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$61.45M-3.3% QoQ
Last fiscal yearDec 2025
$63.54M-17.1% YoY
Year agoMar 2025
$65.45M-6.1% since
Total Current Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-6.1%——
1 year-17.1%——
3-year CAGR-0.9%——
5-year CAGR——
10-year CAGR——

Total Current Liabilities history

USD · from the balance sheet

Latest · FY2025
63.54M USD
Year-over-year change
-17.1%
4-year CAGR
+0.8%

Total Current Liabilities vs competitors

How INGN compares with its peers on the latest reported figures

  • INGN's Mar 2026 total current liabilities of $61.45M is the 2nd highest of the 11 companies compared; the peer median is $18.23M.
  • Its year-over-year change of -6.1% is the 9th highest of 11, against a peer median of +31.9%.
  • Total current liabilities amounts to 21.5% of total assets for INGN, versus a peer median of 12.0%.
INGN Competitors Peer median
Total Current Liabilities for INGN and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
HCATHealth Catalyst, Inc.Mar 2026$107.61M -68.3%+2.8%26.1%
INGNInogen, Inc.Mar 2026$61.45M -6.1%-0.9%21.5%
QTRXQuanterix CorporationMar 2026$49.91M +23.5%+33.6%13.6%
OMOutset Medical, Inc.Mar 2026$37.61M +9.9%-10.2%15.1%
CATXPerspective Therapeutics, Inc.Mar 2026$31.49M +148.3%+120.5%7.7%
SNWVSANUWAVE Health, Inc.Mar 2026$18.3M -61.3%-33.3%49.3%
SGHTSight Sciences, Inc.Mar 2026$18.16M +49.8%-14.8%16.6%
NNOXNano-X Imaging Ltd.Dec 2025$16.89M +20.9%-12.3%10.4%
SIShoulder Innovations, Inc.Mar 2026$12.34M +76.6%—7.7%
EPRXEupraxia Pharmaceuticals Inc.Mar 2026$7.39M +235.8%+10.8%5.1%
HSDTSolana CompanyMar 2026$2.81M +40.3%+14.9%1.4%
Peer median (excluding INGN) $18.23M+31.9%+2.8%12.0%

Competitors are the stored peer set for INGN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents235.52M187.01M125.49M113.8M103.73M
Short-term Investments9.99M02.98M015.85M
Net Receivables25.8M64.35M42.91M30.1M38.86M
Inventory31.87M34.09M21.84M24.81M25.97M
Other Current Assets019.19M13.85M16.74M13.89M
Total Current Assets329.19M304.65M207.07M185.45M198.3M
Property, Plant & Equipment (Net)63.84M64.92M70.65M62.7M52.86M
Goodwill32.98M32.85M10.06M9.47M10.7M
Intangible Assets60.15M177K34.59M30.49M30.76M
Long-term Investments00000
Tax Assets00000
Other Non-current Assets3.36M2.45M3.83M8.08M6M
Total Non-current Assets160.33M100.4M119.13M110.73M100.33M
Total Assets489.51M405.04M326.19M296.19M298.63M
Account Payables10.26M18.24M13.45M16.62M20.26M
Short-term Debt00000
Tax Payables561K492K27K142K183K
Deferred Revenue8.57M8.88M7.98M6.65M5.5M
Other Current Liabilities6.48M7.79M19.63M22.74M10.12M
Total Current Liabilities61.51M65.35M72.5M76.69M63.54M
Long-term Debt00000
Deferred Tax Liabilities008.54M6.95M6.75M
Deferred Revenue (Non-current)11.86M10.4M8.23M5.75M3.6M
Other Non-current Liabilities22.63M12.12M13.85M16.35M18.19M
Total Non-current Liabilities57.77M42.29M48.89M45.64M42.86M
Total Liabilities119.29M107.64M121.38M122.33M106.39M
Common Stock23K23K23K24K27K
Retained Earnings69.27M(14.5M)(116.95M)(152.84M)(175.58M)
Accumulated OCI1.47M(243K)1.23M(1.5M)4.24M
Other Stockholders Equity00000
Minority Interest00000
Total Equity370.23M297.41M204.81M173.86M192.23M
Total Debt26.67M23.28M21.92M19.41M17.48M
Net Debt(208.85M)(163.74M)(103.57M)(94.39M)(86.25M)

Inogen, Inc.

NASDAQ:INGN

Intrinsic Alpha fair value

Locked

Current Price

$5.57

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.